Paralogue | Variant | Associated Disease | Mapping Quality | Consensus | Pubmed |
---|---|---|---|---|---|
SCN1A | R377Q | Generalized epilepsy with febrile seizures plus | High | 9 | 18413471, 26096185 |
SCN1A | R377L | Dravet syndrome | High | 9 | 18076640 |
To assess whether the paralogue annotation here confidently predicts that variation at this residue is pathogenic, it is important to check the reports in the Pubmed links above to ascertain that the mutations in these paralogues have been proved likely to be disease-causing. It is also important to check that the direction of effect of the variant in the paralogue is compatible with your observed phenotype in SCN5A.
SCN5A | EGYRCLKAGENPDHGYTSFDSFAWAFLALF>R<LMTQDCWERLYQQTLRSAGKIY-MIFFMLV | 396 |
SCN1A | EGYMCVKAGRNPNYGYTSFDTFSWAFLSLF>R<LMTQDFWENLYQLTLRAAGKTY-MIFFVLV | 406 |
SCN2A | EGYICVKAGRNPNYGYTSFDTFSWAFLSLF>R<LMTQDFWENLYQLTLRAAGKTY-MIFFVLV | 408 |
SCN3A | EGYICVKAGRNPNYGYTSFDTFSWAFLSLF>R<LMTQDYWENLYQLTLRAAGKTY-MIFFVLV | 407 |
SCN4A | EGYECIKTGRNPNYGYTSYDTFSWAFLALF>R<LMTQDYWENLFQLTLRAAGKTY-MIFFVVI | 430 |
SCN7A | EGYVCVKAGINPDQGFTNFDSFGWALFALF>R<LMAQDYPEVLYHQILYASGKVY-MIFFVVV | 377 |
SCN8A | EGYQCMKAGRNPNYGYTSFDTFSWAFLALF>R<LMTQDYWENLYQLTLRAAGKTY-MIFFVLV | 394 |
SCN9A | EGYTCVKIGRNPDYGYTSFDTFSWAFLALF>R<LMTQDYWENLYQQTLRAAGKTY-MIFFVVV | 385 |
SCN10A | DGYICLKTSDNPDFNYTSFDSFAWAFLSLF>R<LMTQDSWERLYQQTLRTSGKIY-MIFFVLV | 380 |
SCN11A | IQYECKHTKINPDYNYTNFDNFGWSFLAMF>R<LMTQDSWEKLYQQTLRTTGLYS-VFFFIVV | 383 |
CACNA1A | NGTKCQPYWEGPNNGITQFDNILFAVLTVF>Q<CITMEGWTDLLYNSNDASGNTWNWLYFIPL | 343 |
CACNA1B | GDTECREYWPGPNFGITNFDNILFAILTVF>Q<CITMEGWTDILYNTNDAAGNTWNWLYFIPL | 339 |
CACNA1C | -GTVCKPGWDGPKHGITNFDNFAFAMLTVF>Q<CITMEGWTDVLYWVNDAVGRDWPWIYFVTL | 388 |
CACNA1D | NGTECRSGWVGPNGGITNFDNFAFAMLTVF>Q<CITMEGWTDVLYWVNDAIGWEWPWVYFVSL | 389 |
CACNA1E | AGYEC-KDWIGPNDGITQFDNILFAVLTVF>Q<CITMEGWTTVLYNTNDALGATWNWLYFIPL | 334 |
CACNA1F | NQTECRGRWPGPNGGITNFDNFFFAMLTVF>Q<CVTMEGWTDVLYWMQDAMGYELPWVYFVSL | 355 |
CACNA1G | YYTNCSAGEHNPFKGAINFDNIGYAWIAIF>Q<VITLEGWVDIMYFVMDAHSF-YNFIYFILL | 378 |
CACNA1H | YYNVCRSGDSNPHNGAINFDNIGYAWIAIF>Q<VITLEGWVDIMYYVMDAHSF-YNFIYFILL | 402 |
CACNA1I | YYNVCRTGSANPHKGAINFDNIGYAWIVIF>Q<VITLEGWVEIMYYVMDAHSF-YNFIYFILL | 381 |
CACNA1S | NGSECRGGWPGPNHGITHFDNFGFSMLTVY>Q<CITMEGWTDVLYWVNDAIGNEWPWIYFVTL | 317 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R367C | c.1099C>T | Inherited Arrhythmia | LQTS,BrS | rs199473097 | SIFT: deleterious Polyphen: probably damaging |
Reports | Inherited Arrhythmia | BrS | Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol. 2002 40(2):350-6. 12106943 | ||
Inherited Arrhythmia | BrS | Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm. 2009 6(3):341-8. 19251209 | |||
Inherited Arrhythmia | LQTS | Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009 6(9):1297-303. 19716085 | |||
Inherited Arrhythmia | BrS | An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010 7(1):33-46. 20129283 | |||
Inherited Arrhythmia | BrS | Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. J Med Genet. 2014 51(1):35-44. doi: 10.1136/jmedgenet-2013-101917. 24136861 | |||
p.R367H | c.1100G>A | Inherited Arrhythmia | BrS | rs28937318 | SIFT: deleterious Polyphen: probably damaging |
Reports | Other Cardiac Phenotype | Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet. 2002 11(3):337-45. 11823453 | |||
Inherited Arrhythmia | BrS | A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med. 2004 255(1):137-42. 14687250 | |||
Inherited Arrhythmia | BrS | Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol. 2004 15(1):64-9. 15028074 | |||
Inherited Arrhythmia | BrS | Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm. 2009 6(3):341-8. 19251209 | |||
Other Cardiac Phenotype | Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol. 2011 4(6):874-81. 22028457 | ||||
Inherited Arrhythmia | BrS | An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010 7(1):33-46. 20129283 | |||
Other Cardiac Phenotype | Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atrioventricular block. Circulation. 2012 126(12):1469-77. doi: 10.1161/CIRCULATIONAHA.111.0 22899775 | ||||
Inherited Arrhythmia | BrS | Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. J Med Genet. 2014 51(1):35-44. doi: 10.1136/jmedgenet-2013-101917. 24136861 | |||
p.R367L | c.1100G>T | Inherited Arrhythmia | BrS | rs28937318 | SIFT: deleterious Polyphen: probably damaging |
Reports | Inherited Arrhythmia | BrS | An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010 7(1):33-46. 20129283 | ||
Inherited Arrhythmia | BrS | Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. J Med Genet. 2014 51(1):35-44. doi: 10.1136/jmedgenet-2013-101917. 24136861 |